CORO1A and neoplasm: Supplementation with the same quantity of EVs from MC38 cells (MC38‐EVs) and from MC38‐Coro1a−/‐ cells (MC38‐Coro1a−/−‐EVs) equally rescued the growth inferiority of Coro1a−/− tumour and shortened the survival (Figure 7a, b), suggesting that Coro1a knockout did not alter EV function.